Skip to main content
Equibles

RHUMBLINE ADVISERS

Position in TMDX — TransMedics Group, Inc.

CIK 1115418 BOSTON, MA
Back to TMDX Full portfolio

Position in TMDX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$5,328,212
-$3,601,191 QoQ
Shares Held
80,220
-10.7% QoQ
Ownership
0.231%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 372 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 52% Shared 0% None 48%

Common Shares in TMDX Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,271,214,892 across 85 Medical Devices names. TMDX ranks #20 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 2,820,543 $255,936,071
2 SYK
Stryker Corp
 616,745 $194,175,995
3 MDT
Medtronic plc
 2,213,044 $173,126,432
4 BSX
Boston Scientific Corp
 2,641,843 $112,753,859
5 EW
Edwards Lifesciences Corp
 1,096,770 $99,213,814
6 DXCM
Dexcom Inc
 768,165 $51,735,912
7 GEHC
GE HealthCare Technologies Inc.
 755,006 $48,327,934
8 STE
STERIS plc
 217,541 $45,807,608

All Filings in TMDX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,328,212 80,220
2026-03-31 $8,929,403 89,824
2025-12-31 $10,709,579 88,036
2025-09-30 $10,472,972 93,342
2025-06-30 $12,492,010 93,217
2025-03-31 $6,023,174 89,524
2024-12-31 $5,615,303 90,061
2024-09-30 $10,412,083 66,319
2024-06-30 $7,176,289 47,645
2024-03-31 $3,391,036 45,862
2023-12-31 $3,596,129 45,561
2023-09-30 $2,551,076 46,595
2023-06-30 $3,818,738 45,472
2023-03-31 $3,215,192 42,456
2022-12-31 $2,470,960 40,035
2022-09-30 $1,510,278 36,183
2022-06-30 $973,346 30,949
2022-03-31 $679,022 25,205
2021-12-31 $451,869 23,584
2021-09-30 $792,670 23,955
2021-06-30 $756,139 22,789
2021-03-31 $972,525 23,440
2020-12-31 $484,087 24,326
2020-09-30 $296,573 21,522
2020-06-30 $381,839 21,308
2020-03-31 $159,794 13,228